Evidence map›Paper›PMID 30410044›Full record

ArticleScientific reports2018

Exosomes exert cardioprotection in dystrophin-deficient cardiomyocytes via ERK1/2-p38/MAPK signaling.

Melanie Gartz, Ashley Darlington, Muhammed Zeeshan Afzal, Jennifer L Strande

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Melanie GartzCardiovascular Center, Medical College of Wisconsin, Milwaukee, WI, USA.
Ashley DarlingtonCardiovascular Center, Medical College of Wisconsin, Milwaukee, WI, USA.
Muhammed Zeeshan AfzalCardiovascular Center, Medical College of Wisconsin, Milwaukee, WI, USA.
Jennifer L StrandeCardiovascular Center, Medical College of Wisconsin, Milwaukee, WI, USA. jstrande@mcw.edu.ORCID http://orcid.org/0000-0002-5918-230X
Medical College of Wisconsin · US

Funding

Developing nicorandil and companion biomarkers for DMD cardiomyopathy therapyR01HL134932 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LAWLOR, MICHAEL WILLIAM · 2017 to 2020
$1.8M
NHLBI NIH HHS R01 HL134932U.S. Department of Health & Human Services | National Institutes of Health (NIH) K08HL11148
6 · The paper itself

Abstract

As mediators of intercellular communication, exosomes containing molecular cargo are secreted by cells and taken up by recipient cells to influence cellular phenotype and function. Here we have investigated the effects of exosomes in dystrophin-deficient (Dys) induced pluripotent stem cell derived cardiomyocytes (iCMs). Our data demonstrate that exosomes secreted from either wild type (WT) or Dys-iCMs protect the Dys-iCM from stress-induced injury by decreasing reactive oxygen species and delaying mitochondrial permeability transition pore opening to maintain the mitochondrial membrane potential and decrease cell death. The protective effects of exosomes were dependent on the presence of exosomal surface proteins and activation of ERK1/2 and p38 MAPK signaling. Based on our findings, the acute effects of exosomes on recipient cells can be initiated from exosome membrane proteins and not necessarily their internal cargo.

Indexed as

MAP Kinase Signaling SystemCell DifferentiationCells, CulturedCell SurvivalDystrophinExosomesHumansInduced Pluripotent Stem CellsMembrane Potential, MitochondrialMitochondriaMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein KinasesMyocytes, Cardiacp38 Mitogen-Activated Protein KinasesSequence DeletionDMD protein, humanDystrophinMAPK1 protein, humanMAPK3 protein, humanMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein Kinases

Identifiers

PMID30410044
PMCPMC6224575
OpenAlexW2899093156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.